Posted inBiotechnology
Lassa Virus Evades Immune Defenses in Natal Mouse
In a groundbreaking study published in npj Viruses, researchers have shed new light on the sophisticated mechanisms employed by Lassa…
Posted inBiotechnology
Breakthrough Material Design Delivers Massive Cooling Power and Outstanding Durability in Magnetic Refrigeration
A groundbreaking advancement in magnetic refrigeration technology has emerged from an international collaboration of leading research institutions, including Japan’s National…
Posted inBiotechnology
Purdue Researchers Develop Wireless Sensor to Monitor Subsoil Health, Enhancing Precision Farming and Reducing Costs
In a groundbreaking advancement poised to revolutionize agricultural monitoring, Purdue University researchers have developed an innovative smart platform capable of…
Posted inBiotechnology
Quantitative NK-Cell Analysis via Label-Free Flow Imaging
In a groundbreaking investigation, researchers have delved into the potential of label-free flow-imaging microscopy as a novel approach for the…
Posted inBiotechnology
IRB Barcelona Unveils Spain’s First Comprehensive Spatial Omics Platform
In a groundbreaking advancement for biomedical science, the Institute for Research in Biomedicine (IRB Barcelona) has unveiled Spain’s first fully…
Posted inBiotechnology
Histone Lactylation Drives Immune Escape in Pancreatic Cancer
In a groundbreaking study published in Nature Communications, researchers have revealed a novel epigenetic mechanism driving immune evasion in pancreatic…
Posted inBiotechnology
Kailera, Hengrui tout up to 12% weight loss in midstage study for obesity pill
In October of last year, Kailera Therapeutics unveiled a whopping $600 million series B financing raised to fund a phase…
Posted inBiotechnology
Innovative Land-Based Aquaculture Thrives with “The New Type of Water” Featured in University Admissions Listening Test
In a groundbreaking development that could revolutionize the global aquaculture industry, a new land-based fish farming technique has recently attracted…
Posted inBiotechnology
OrsoBio hits target in midstage study for metabolic conditions but stays silent on details
OrsoBio’s experimental oral drug lowered fasting triglyceride levels at four weeks of treatment, hitting the primary efficacy goal in a…
Posted inBiotechnology
FDA rejects Regenxbio’s gene therapy in Hunter syndrome, leaving CEO ‘concerned’
After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the…